Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire SP4 0JQ, UK.
Microbiology (Reading). 2011 Nov;157(Pt 11):3172-3179. doi: 10.1099/mic.0.052902-0. Epub 2011 Aug 18.
Francisella tularensis is an intracellular pathogen which causes tularaemia. There is no licensed vaccine currently available for prophylaxis. The γ-glutamyl transpeptidase (GGT) encoded by the ggt gene has been shown to be important for the intracellular survival of F. tularensis. In this study we have constructed a ggt deletion mutant in the highly virulent F. tularensis strain SCHU S4. Characterization of the mutant strain confirmed the function of ggt, and confirmed the role of GGT in cysteine acquisition. The mutant strain was highly attenuated both in vitro and in vivo using murine models of infection. Moreover, we have demonstrated that the attenuated mutant is able to induce protective immunity against an F. tularensis SCHU S4 challenge, and thus may be a candidate for the development of an attenuated vaccine.
土拉弗朗西斯菌是一种细胞内病原体,可引起土拉菌病。目前尚无可用的预防疫苗。γ-谷氨酰转肽酶(GGT)由 ggt 基因编码,对土拉弗朗西斯菌的细胞内生存至关重要。在这项研究中,我们构建了一种高度毒力的土拉弗朗西斯菌 SCHU S4 菌株中的 ggt 缺失突变体。突变菌株的特性证实了 ggt 的功能,并证实了 GGT 在半胱氨酸获取中的作用。该突变株在体外和体内的感染小鼠模型中均高度减毒。此外,我们已经证明,减毒突变株能够诱导针对土拉弗朗西斯菌 SCHU S4 挑战的保护性免疫,因此可能是开发减毒疫苗的候选者。